03759 PHARMARON
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.80X | Oper Margin | 20.0% |
|---|---|---|---|
| LT Debt/Equity | 35.1% | Net Margin | 14.6% |
| Total Debt/Equity | 43.9% | Return on Equity | 13.2% |
| Price/Book | 2.95X | Return on Assets | 7.5% |
| (HKD 24.160) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 1,907.23 | 1,764.73 | 1,540.64 | 2,031.20 | 1,390.68 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +8.1 | +14.5 | -24.2 | +46.1 | +127.4 |
| Earnings Per Share (HKD) | 1.078 | 0.996 | 0.869 | 1.141 | 0.782 |
| Earnings Per Share Growth (%) | +8.2 | +14.6 | -23.8 | +45.9 | +90.0 |
| Dividend Per Share (HKD) | 0.219 | 0.220 | 0.219 | 0.235 | 0.161 |
| P/E* (X) | 22.42 | 24.26 | 27.81 | 21.18 | 30.90 |
| Yield (%) | 0.91 | 0.91 | 0.91 | 0.97 | 0.67 |
| Dividend Share (%) | 20.30 | 22.08 | 25.22 | 20.58 | 20.60 |
| Book NAV (HKD) | 8.178 | 7.746 | 6.620 | 6.934 | 5.890 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 6,441 | 5,604 | +14.9 | 5,640 |
| Operating Result | 845.387 | 1,248 | -32.3 | 897.422 |
| Associates | -32.657 | -30.306 | +7.8 | 10.982 |
| Profit Before Taxation | 812.756 | 1,227 | -33.8 | 908.525 |
| Taxation | 160.126 | 143.905 | +11.3 | 124.457 |
| Profit /( Loss) After Taxation | 652.63 | 1,083 | -39.7 | 784.068 |
| Minority Interests | -48.766 | -30.457 | +60.1 | -2.025 |
| Net Profit | 701.396 | 1,113 | -37.0 | 786.093 |
| Earnings Per Share () | 0.4365 | 0.6751 | -35.3 | 0.4794 |
| Announcement Date | 2025-08-21 | 2024-08-27 | NA | 2023-08-27 |
* Annualised
Last Update Time: 2025-09-08 21:40:25
